U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527754) titled 'S100B Protein: a Diagnostic Aid in Episodes of Transient Loss of Consciousness?' on April 07.
Brief Summary: S100B protein is a biomarker produced mainly by astrocytes and released into the bloodstream in the event of brain injury, with levels rising rapidly and markedly in acute conditions such as traumatic brain injury, stroke, or epileptic seizures, before declining quickly. Increased S100B levels following a convulsive seizure have been reported, suggesting potential value in distinguishing epilepsy from other causes; however, its use in the etiological assessment of transient loss of consciousness has not yet been studied. Los...